Journal of Parasitic Diseases

, Volume 35, Issue 2, pp 148–154 | Cite as

An ophthalmologist survey-based study of the atypical presentations and current treatment practices of ocular toxoplasmosis in India

  • Soumyava BasuEmail author
  • Jyotirmay Biswas
  • Uwe Pleyer
  • Avinash Pathangay
  • B. Manohar Babu
Original Article


The last two decades have seen a paradigm shift in the understanding of ocular toxoplasmosis. Post-natally acquired infection with its atypical presentations, has emerged as a common form of the disease. We conducted a questionnaire-based survey to investigate the characteristics of atypical presentations and current treatment practices of ocular toxoplasmosis, in India. A written questionnaire was distributed to ophthalmologists at two major uveitis meetings, held in Hyderabad, India in January, 2009. It evaluated characteristics of atypical presentations of ocular toxoplasmosis and specific treatment-related issues in India. Of 37 respondents who completed the questionnaire, 28 (75.6%) found atypical presentations in less than one-fourth of ocular toxoplasmosis patients. Atypical presentations were mostly seen as primary retinitis lesion, and in healthy immuno-competent individuals. Most ophthalmologists (n = 28, 75.6%) thought viral retinitis to be the most common differential diagnosis for atypical ocular toxoplasmosis and relied on serological tests (n = 19, 51.3%) for the diagnosis. Twenty-three (62.1%) respondents treated all patients with active lesions. A diverse range of treatment regimens were used, trimethoprim-sulphamethoxazole combination being most common (n = 12, 32.4%). Corticosteroids were included in all regimens. Atypical presentations of ocular toxoplasmosis were identified by all ophthalmologists, participating in the survey, though not commonly by most. Treatment practices were diverse, reflecting the lack of consensus on this issue.


Atypical Ocular Survey Toxoplasmosis Treatment 



Hyderabad Eye Research Foundation, Hyderabad.


  1. Bosch-Driessen EH, Rothova A (1998) Sense and nonsense of corticosteroid administration in the treatment of ocular toxoplasmosis. Br J Ophthalmol 82:858–860PubMedCrossRefGoogle Scholar
  2. Delair E, Monnet D, Grabar S et al (2008) Respective roles of congenital and acquired infections in presumed acquired ocular toxoplasmosis. Am J Ophthalmol 146:851–855PubMedCrossRefGoogle Scholar
  3. Dhumne M, Sengupta C, Kadival G et al (2007) National seroprevelance of Toxoplasma gondii in India. J Parasitol 93:1520–1521PubMedCrossRefGoogle Scholar
  4. Engstrom RE Jr, Holland GN, Nussenblatt RB et al (1991) Current practices in the management of ocular toxoplasmosis. Am J Ophthalmol 111:601–610PubMedGoogle Scholar
  5. Fardeau C, Romand S, Rao NA et al (2002) Diagnosis of toxoplasmic retinochoroiditis with atypical clinical features. Am J Ophthalmol 134:196–203PubMedCrossRefGoogle Scholar
  6. Gilbert RE, Stanford MR (2000) Is ocular toxoplasmosis caused by prenatal or postnatal infection? Br J Ophthalmol 84:224–226PubMedCrossRefGoogle Scholar
  7. Holland GN (1999) Reconsidering the pathogenesis of ocular toxoplasmosis. Am J Ophthalmol 128:502–505PubMedCrossRefGoogle Scholar
  8. Holland GN (2003) Ocular toxoplasmosis: a global reassessment. Part I: epidemiology and course of disease. Am J Ophthalmol 136:973–988PubMedCrossRefGoogle Scholar
  9. Holland GN (2004) Ocular toxoplasmosis:a global reassessment. Part II: disease manifestations and management. Am J Ophthalmol 137:1–17PubMedGoogle Scholar
  10. Holland GN, Lewis KG (2002) An update on current practices in the management of ocular toxoplasmosis. Am J Ophthalmol 134:102–114PubMedCrossRefGoogle Scholar
  11. Holland GN, Engstrom RE Jr, Glasgow BJ et al (1988) Ocular toxoplasmosis in patients with acquired immunodeficiency syndrome. Am J Ophthalmol 106:653–667PubMedGoogle Scholar
  12. Johnson MW, Greven GM, Jaffe GJ et al (1997) Atypical, severe toxoplasmic retinochoroiditis in elderly patients. Ophthalmology 104:48–57PubMedGoogle Scholar
  13. Jones JL, Kruszon-Moran D, Wilson M et al (2001) Toxoplasma gondii infection in the United States: seroprevalence and risk factors. Am J Epidemiol 154:357–365PubMedCrossRefGoogle Scholar
  14. Lum F, Jones JL, Holland GN et al (2005) Survey of ophthalmologists about ocular toxoplasmosis. Am J Ophthalmol 140:724–726PubMedCrossRefGoogle Scholar
  15. Mahalakshmi B, Therese KL, Madhavan HN et al (2006) Diagnostic value of specific antibody production and nucleic acid amplification technique-nested polymerase chain reaction (nPCR) in clinically suspected ocular toxoplasmosis. Ocul Immunol Inflamm 14:105–112PubMedCrossRefGoogle Scholar
  16. Montoya JG, Liesenfeld O (2004) Toxoplasmosis. Lancet 363:1965–1976PubMedCrossRefGoogle Scholar
  17. Montoya JG, Remington JS (1996) Toxoplasmic chorioretinitis in the setting of acute acquired toxoplasmosis. Clin Infect Dis 23:277–282PubMedCrossRefGoogle Scholar
  18. Ongkosuwito JV, Bosch-Driessen EH, Kijlstra A et al (1999) Serologic evaluation of patients with primary and recurrent ocular toxoplasmosis for evidence of recent infection. Am J Ophthalmol 128:407–412PubMedCrossRefGoogle Scholar
  19. Ronday MJ, Luyendijk L, Baarsma GS et al (1995) Presumed ocular acquired toxoplasmosis. Arch Ophthalmol 113:1524–1529PubMedCrossRefGoogle Scholar
  20. Rothova A, Meenken C, Buitenhuis HJ et al (1993) Therapy for ocular toxoplasmosis. Am J Ophthalmol 115:517–523PubMedGoogle Scholar
  21. Silveira C, Belfort R Jr, Burnier M et al (1988) Acquired toxoplasmic infection as the cause of toxoplasmic retinochoroiditis in families. Am J Ophthalmol 106:362–364PubMedCrossRefGoogle Scholar
  22. Smith JR, Cunningham ET Jr (2002) Atypical presentations of ocular toxoplasmosis. Curr Opin Ophthalmol 13:387–392PubMedCrossRefGoogle Scholar
  23. Soheilian M, Sadoughi MM, Ghajarnia M et al (2005) Prospective randomized trial of trimethoprim/sulphamethoxazole versus pyrimethamine and sulphadiazine in the treatment of ocular toxoplasmosis. Ophthalmology 112:1876–1882PubMedCrossRefGoogle Scholar
  24. Stanford MR, See SE, Jones LV et al (2003) Antibiotics for toxoplasmic retinochoroiditis: an evidence-based systematic review. Ophthalmology 110(5):926–931PubMedCrossRefGoogle Scholar
  25. Talabani H, Asseraf M, Yera H et al (2009) Contributions of immunoblotting, real-time PCR and Goldman-Witmer co-efficient to the diagnosis of atypical toxoplasmic retinochoroiditis. J Clin Microbiol 47:2131–2135. doi: 10.1128/JCM.00128-09 PubMedCrossRefGoogle Scholar
  26. Torun N, Sherif Z, Garweg J et al (2008) Diagnosis and treatment of ocular toxoplasmosis: a survey of German speaking ophthalomologists. Ophthalmologe 105:1023–1028PubMedCrossRefGoogle Scholar

Copyright information

© Indian Society for Parasitology 2011

Authors and Affiliations

  • Soumyava Basu
    • 1
    Email author
  • Jyotirmay Biswas
    • 2
  • Uwe Pleyer
    • 3
  • Avinash Pathangay
    • 4
  • B. Manohar Babu
    • 5
  1. 1.LV Prasad Eye InstituteBhubaneswarIndia
  2. 2.Sankara NethralayaChennaiIndia
  3. 3.Department of OphthalmologyCharité, Humboldt UniversityBerlinGermany
  4. 4.LV Prasad Eye InstituteVishakhapatnamIndia
  5. 5.Aravind Eye HospitalCoimbatoreIndia

Personalised recommendations